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Abstract
Rho-associated coiled coil containing protein kinase (Rho-kinase or Rock) is a well-defined determinant of actin organization
and dynamics in most animal cells characterized to date. One of the primary effectors of Rock is non-muscle myosin II.
Activation of Rock results in increased contractility of myosin II and subsequent changes in actin architecture and cell
morphology. The regulation of Rock is thought to occur via autoinhibition of the kinase domain via intramolecular
interactions between the N-terminus and the C-terminus of the kinase. This autoinhibited state can be relieved via
proteolytic cleavage, binding of lipids to a Pleckstrin Homology domain near the C-terminus, or binding of GTP-bound RhoA
to the central coiled-coil region of Rock. Recent work has identified the Shroom family of proteins as an additional regulator
of Rock either at the level of cellular distribution or catalytic activity or both. The Shroom-Rock complex is conserved in most
animals and is essential for the formation of the neural tube, eye, and gut in vertebrates. To address the mechanism by
which Shroom and Rock interact, we have solved the structure of the coiled-coil region of Rock that binds to Shroom
proteins. Consistent with other observations, the Shroom binding domain is a parallel coiled-coil dimer. Using biochemical
approaches, we have identified a large patch of residues that contribute to Shrm binding. Their orientation suggests that
there may be two independent Shrm binding sites on opposing faces of the coiled-coil region of Rock. Finally, we show that
the binding surface is essential for Rock colocalization with Shroom and for Shroom-mediated changes in cell morphology.
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Introduction
Coordinated cellular processes that alter cell and tissue
morphology, such as apical constriction, are often driven by
the assembly and activation of contractile networks of F-actin
and non-muscle myosin II (reviewed in [1]). This contractility
and the resulting changes in cell shape are required for the
proper development of numerous tissues including the vascula-
ture, heart, central nervous system, kidney, and gut [2–14]. The
signaling and mechanistic aspects of apical constriction have
been widely studied and have recently been placed in a cellular
framework. It has been shown in several cellular and genetic
model systems that apical constriction is driven largely by the
pulsatile contraction of a cortical mesh of actin bundles that are
indirectly linked to the apically positioned cell-cell adhesions
mediated by the cadherins. The mechanical force for contrac-
tion is supplied by motor activity of myosin II (reviewed in [15]).
The trigger for apical constriction comes via signaling pathways
that result in the phosphorylation of myosin regulatory light
chain (MRLC) at serine19, which is correlated with actin-
stimulated ATPase activity, suggesting this modification is
driving changes in cytoskeletal architecture [16,17]. MRLC
phosphorylation at serine 19 has been reported for several
kinases including Calcium/Calmodulin dependent protein
kinase [18], Protease activated protein kinase I [19], and Rho-
associated kinase (Rock) [20], suggesting that myosin contrac-
tility and cytoskeletal dynamics are cellular characteristics that
are regulated by a wide range of environmental cues.
Vertebrates have two highly related Rock proteins, Rock1 and
Rock2, which share 65% sequence identity to each other. Both
contain an N-terminal kinase domain, a centrally located coiled
coil region and C-terminal pleckstrin homology (PH) and cysteine-
rich domains. The Rock kinase domain has a typical Ser/Thr
kinase fold, similar to protein kinase A, consisting of two kinase
lobes linked by a hinge [21]. N-terminal and C-terminal
extensions from the kinase domain facilitate dimerization and
are also required for activity [22,23]. The kinase domains dimerize
in a head-to-head arrangement with active sites located along a
single face of the dimer and positioning the adjacent sequences for
coiled-coil formation [22].
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Rock catalytic activity is inhibited by a direct intramolecular
interaction between the kinase domain and sequences within a
large C-terminal fragment of Rock containing 200 residues of
the coiled-coil region, the PH domain , and the cysteine-rich
domain [24] (Figure 1A). Relief of Rock autoinhibition can be
achieved through several independent mechanisms involving
interaction or modification with this autoinhibitory region.
These include lipid binding to the PH domain [25,26], removal
of the PH domain via proteolytic cleavage by Caspase-3 [27,28],
or the binding of other proteins such as Dynamin I [29] or the
small GTPase RhoA [30]. Of these, the interaction with RhoA
is probably the most intensely studied and widely utilized at the
cell and organismal level. RhoA recognizes binding sites within
the coiled-coil region of Rock in a GTP dependent manner [30]
using canonical Switch I and II loops [31]. Structural studies
have shown that the Rho-binding domain (RBD) is maintained
as a parallel dimeric coiled-coil after RhoA binding with the
RhoA interface composed of residues from both Rock proteins
[31,32]. Other RhoA interacting proteins, such as Protein-
kinase N, use a single chain antiparallel coiled-coil to bind a
separate surface on RhoA, thus highlighting the mechanistic
diversity this class of effector proteins can use to modulate
function [33].
The Shroom (Shrm) family of actin-binding proteins play
essential roles in the development of multiple tissues, including the
nervous system, eyes, heart, vasculature, and gut, by mediating the
formation of contractile actomyosin networks that guide changes
in cell shape and migration [3,8–10,14,34–40]. Of the four
vertebrate family members, Shrm3 is the most extensively
characterized and serves as a model for the function of other
Shrm proteins. Using both animal models and in vitro cell culture
systems, Shrm3 has been shown to elicit apical constriction, a
behavior of epithelial cells that results in decreased apical area and
is thought to facilitate developmental processes such as tissue
invagination and bending [8,36,37,41]. To accomplish this task,
Shrm3 is localized to apically positioned sites of cell-cell adhesion
in polarized cells, where it directly interacts with Rock through a
highly conserved domain on its C-terminus called the Shrm
Domain 2 (SD2). The interaction between the SD2 and Rock is
essential for Shrm3-induced apical constriction. Although several
Rock effectors are linked to regulation of the cytoskeleton,
previous studies indicate that Rock elicits apical constriction
through the activation of non-muscle myosin II, as inhibition of
Rock or Myosin II has been shown to prevent Shrm3-induced
apical constriction [36]. The SD2 domain is an unusual three-
segmented antiparallel coiled-coil that contains no sequence or
Figure 1. A Central region within the coiled-coil domain interacts with Shrm SD2. A) Diagram of Rock1 domain structure. Domains and
their boundaries within Rock1 are indicated. N- and C-terminal extensions on the Rock1 kinase domain are shown in red. Sequence conservation from
a multiple sequence alignment of 22 Rock sequences is shown with sequence positions containing 90% identity indicated in blue. B) Identification of
a minimal Shrm SD2 binding domain within Rock1. Purified untagged human Shrm2 SD2 was mixed with beads pre-bound to the indicated his-
tagged fragment of Rock1. Complexes were precipitated by spinning down the beads and the resulting samples were resolved on SDS-PAGE. P,
pelleted beads; S supernatant. C) Rock fragments were assayed for binding to Shrm SD2. Increasing concentrations of Rock1 (707–946) or (834–913)
were added to a reaction mixture containing 50 nM Oregon-Green labeled human Shrm2 SD2 domain in a fluorescence spectrophotometer. The
binding isotherm was fit to Equation 1 using a non-linear regression to determine binding affinity (Kd).
doi:10.1371/journal.pone.0081075.g001
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structural homology to other Rock activators [42], and thus it is
unclear how SD2 binding regulates Rock kinase activity. Shrm3
may function to localize Rock to the apical surface where it is
then activated by another signal or, alternatively, Shrm3 may
function to both recruit and activate Rock. In either scenario,
the Shrm-Rock interaction results in the assembly of a
contractile actomyosin network in the zonula adherens and
subsequent constriction of the apical domain of the cell.
Previous studies indicate all Shrm family proteins may function
in an analogous manner and that the Shrm-Rock complex is
conserved in most animals [34,35,43–45]. However, not all
Shrm proteins exhibit the same subcellular distribution,
suggesting that an important aspect of Shrm activity may be
to initiate myosin II activity in different regions of the cell in
order to elicit different cellular behaviors [44].
In order to gain insight into the mechanism of Shrm-mediated
activation of Rock, we have identified a minimal stable domain
within the coiled-coil domain of Rock that facilitates Shrm
binding. We have determined the structure of this domain using x-
ray crystallography, revealing a dimeric, parallel coiled-coil with
conserved surfaces that mediate binding to Shrm and subcellular
colocalization, as well as Shrm-mediated reorganization of the
cytoskeleton and changes in cell shape. These data indicate that
Shrm and Rock comprise a conserved signaling module required
for changes in cell architecture and tissue morphology.
Materials and Methods
Protein expression and purification
Coding sequences for all Rock1 SBD constructs were amplified
by PCR and cloned into the bacterial expression vector pET151-
D/Topo (Invitrogen), which directs expression of an N-terminal
His6 tag that can be removed by digestion with TEV protease.
Protein expression was performed in the bacterial strain
BL21(DE3) codon plus (RIPL) using ZY autoinduction media at
room temperature [46] for ,24 hours. Cells were lysed via
homogenization in 25 mM Tris pH8.0, 500 mM NaCl, 10%
glycerol, 5 mM Imidazole, 5 mM beta-mercaptoethanol. The
lysate was cleared by centrifugation at 100,0006 g prior to
chromatography. Wild-type and SER mutant Rock1 SBD proteins
were purified by nickel affinity chromatography, followed by
overnight digestion with TEV protease. A second round of nickel
affinity purification was performed to remove the liberated His-tag
and TEV protease, followed by anion exchange chromatography
and gel filtration using a Sephacryl S-200 (GE Healthcare). Peak
fractions were pooled and concentrated. Wild-type and mutant
Rock1 SBD were concentrated to 15 mg/ml prior to crystalliza-
tion in 150 mM NaCl, 20 mM HEPES pH 7.5 and 1 mM b-
mercaptoethanol using a Vivaspin concentrator (Millipore) prior
to crystallization. The purity was typically .99% as verified by
SDS-PAGE. Selenomethionine substituted mutant Rock1 SBD
was expressed using PASM media, and purification was essentially
the same as the native protein [46]. Human Shrm2 SD2 domain
(1427–1610) was cloned into the pET151/D-TOPO vector and
expressed in BL21(DE3) Codon+(RILP) using ZY autoinduction
media. The purification was similar as described for Drosophila
Shrm SD2 domain [42].
Mutagenesis of human Rock1 SBD proteins
The surface entropy reduction mutation and all of the
mutations in hRock1 SBD (707–946 and 834–913) were made
using the QuikChange Site-Directed Mutagenesis kit (Stratagene).
The mutant Rock proteins were expressed and purified in a
manner similar to the wild-type proteins.
Crystallization and Structure Determination
Crystals of Rock1 SBD (834–913) containing the SER mutant
were grown using the vapor diffusion technique against a reservoir
solution containing 0.1 M Citrate pH 6.0, and 1.0 M ammonium
sulfate. Crystals were optimized by seeding at 4uC and grow to
3006100650 mm over the course of two weeks. Crystals were
cryoprotected by transition into a buffer containing 0.1 M citrate
pH 6.0, 2.5 M ammonium sulfate, 0.15 M NaCl, and 20%
glycerol and flash frozen under liquid nitrogen prior to data
collection. The same procedure was used to crystallize and
cryoprotect selenomethionine (SeMet) substituted crystals.
Diffraction data from all crystals was collected at beamline X25
at the National Synchrotron Light Source. Integration, scaling,
and merging of diffraction data was performed using HKL2000
[47]. Crystals of Rock1 SBDSER belong to space group C21 with
a = 142.5 A˚, b = 56.2 A˚, c = 80.7 A˚, and b= 119.1u, and are
highly anisotropic with diffraction extending to 2.5 A˚ resolution
in the a* and c* direction but limited to 3.1 A˚ in the b*
direction. Initial phases were obtained from crystals of
selenomethionine substituted protein via the SAD method at
4.0 A˚ using SHELX C/D/E which found all four selenium sites
[48]. Data from these crystals were also highly anisotropic and
the map quality was only sufficient to build an initial model
using Coot [49]. This model was further refined against the
native dataset after ellipsoidal truncation using the diffraction
anisotropy server [50]. The model was improved using a
combination of simulated annealing, rigid body, positional, B-
factor, and TLS refinement within Phenix [51]. Model quality
was monitored using MolProbity [52].
Complex Formation
Wild-type or mutant Rock1 707–946 (10 mM) was mixed with
human Shrm2 SD2 domain (also at 10 mM) and incubated at
room temperature for 20 minutes. Shrm-Rock complexes were
resolved on 12% native PAGE gels run at 4uC and stained with
Coomassie Blue.
Fluorescent Labeling of Human Shroom2 SD2
Recombinant human Shrm2 SD2 domain (1427–1610) was N-
terminally labeled with Oregon Green 488 Succinimidyl ester
(Invitrogen) in amino labeling buffer (20 mM Hepes pH 7.4,
100 mM NaCl, 5% Glycerol) in a manner similar to [53].
Labeling reactions included 106molar excess of fluorophore at
room temperature for 2 h. Excess fluorophore was removed from
the samples through extensive dialysis with labeling buffer. The
labeling efficiency was quantified using the extinction coefficient of
the dye compared with the protein concentration determined from
a standard curve using a Bradford assay and found to be essentially
1:1.
Fluorescence Anisotropy Binding Experiments
Fluorescence anisotropy measurements were performed in
(20 mM Hepes pH 7.4, 100 mM NaCl, 5% Glycerol) using
20 nM of N-terminally labeled Shrm2 SD2-Oregon Green 488
and increasing concentrations of Rock1 SBD. Measurements were
collected as described previously using a Floromax-3 fluorimeter
(Horiba Jobin Yvon) [54]. Labeled proteins were excited at
496 nm and emission was monitored at 524 nm using 5-second
integration times for three consecutive readings. The reported
anisotropy values (r) are the average of at least three independent
experiments and fit by a non-linear least squares analysis using
Kaleidagraph (Synergy, Reading, PA) to a single binding model:
r = (DA6[P])/(Kd+[P]) (Equation 1) where A is the amplitude, P is
Identification of a Shrm-Binding Surface on Rock1
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the concentration of titrated Rock1 SBD, and Kd is the dissociation
constant.
Shrm-Rock Pulldowns
In vitro Pull-down assays were performed using the indicated
His-tagged fragments of human Rock1 and untagged human
Shrm2 SD2 (1427–1610). 25 mg of purified His-tagged Rock
protein was immobilized to 50 ml of nickel beads (Qiagen), and
washed three times with binding buffer (2% glycerol, 100 mM
NaCl, 7 mM Imidazole, 1 mM b-mercaptoethanol, and 20 mM
Tris pH 8.0) to remove unbound protein. A 26molar excess of
untagged Shrm was then incubated with Rock conjugated beads in
binding buffer for 10 minutes at room temperature. Beads were
then spun down and a supernatant sample taken prior to three
washes with binding buffer. The beads were then incubated with
46 SDS-Loading buffer and resolved on 15% SDS-PAGE and
detected by Coomassie staining. Bead control sample was run by
substituting binding buffer for the His-tagged Rock protein. For
pulldowns from cell lysates, 293 cells were transiently transfected
with the indicated Rock-SBD expression plasmids and grown
overnight. Cells were lysed in RIPA buffer and cleared by
centrifugation. Equal amounts of GST or GST-mShroom3 SD2
bound to glutathione sepharose were added to the lysate and
incubated at 4uC for 2 hours with rocking. Beads were washed 3
times with RIPA buffer and resuspended in SDS-PAGE sample
buffer. Total cell lysate and eluted proteins were resolved by SDS-
PAGE, transferred, and detected using mAb 9E10 and Super-
Signal West Pico Chemiluminescent Substrate (Thermo). Lumi-
nescence was detected using Fujifilm LAS-3000 imager. 293HEK
cells were used due to higher transfection efficiency.
Chemical Crosslinking
Wild-type and SBDSER were incubated for 25 minutes with
0.002% glutaraldehyde in a reaction buffer containing 25 mM
HEPES pH 7.5, 8% Glycerol, 500 mM NaCl and 5 mM b-ME,
at a final protein concentration of 26 mM. The crosslinking
reaction was stopped with the addition of Tris pH 8.0 to a final
concentration of 0.2 M. Crosslinked species were then visualized
by SDS-PAGE with Coomassie blue staining.
Immunofluorescence and siRNA mediated knock-down
studies
Cos7 or T23 MDCK cells were grown in DMEM/10% FBS/L-
glut/pen-strep or EMEM/10% FBS/L-glut/pen-strep. Cells were
transfected with indicated expression vectors using Lipofectamine.
Briefly, cells were trypsinized and mixed with DNA/Lipofecta-
mine complexes and plated onto fibronectin-coated cover slides or
transwell filters for 24 hours. Cells were fixed with 4% parafor-
maldehyde and stained to detect Shroom3 (UPT132, [36]), or
myc-tagged hRockI 681–942. Primary antibodies were detected
using Alexa-conjugated secondary antibodies. For Rock knock-
down studies, siRNAs specific for canine Rock1 and Rock2
mRNA were designed using the Dharmacon design tools based
gene accession numbers XM_537305 and XM_540083. Three
siRNAs specific for Rock1 (1.1, GAAAUAGCAAGAGAA-
CUAUU; 1.2, GAGAAUUGAAAGAGAGAAAUU; and 1.3,
GCGAAAUGGUGUAGAAGAAUU) and Rock2 (2.1, UGAAA-
GAAAUGGAGAAGAAUU; 2.2, CGAACAAGAUAAAGAA-
CAAUU; and 2.3, UGAAGAAAGUCAAGAGAUUUU) were
tested for efficient knock-down via western blotting using rabbit
anti-Rock antibodies (Bethyl). Briefly, parental T23 MDCK cells
were transfected with individual siRNAs (10 ml of 20 mM siRNAs
in a final volume of 2 ml) and cells were grown for 3 days prior to
lysis and blotting. siRNAs 1.2 and 2.1 were used for all subsequent
experiments. T23 MDCK+EndoShrm3 cells (56105) were trans-
fected with 5 mL of Lipofectamine 2000 and 10 mL (20 mM) each
siRNA in a final volume of 2 mL in a 35 mm plate. After two
days, doxycycline was withdrawn to induce the expression of
Endo-Shrm3. After 48 hours of siRNA transfection, cells were
transiently transfected with expression plasmids for Rock1 variants
using Lipofectamine as previously described [36]. Cells were
plated onto transwell membranes and allowed to grow overnight.
Membranes were then stained to detect Rock1 and ZO1. Images
were captured using either an Olympus Flo-View or Bio-Rad
Radiance confocal microscope. Images were processed using
either Photoshop or ImageJ. For quantifying rescue of apical
constriction by the various Rock proteins, the apical areas of only
Rock-expressing cells was measured using ImageJ. The apical area
was considered to be that region of the cell encircled by ZO1
staining. Statistical significance was determined using Students t-
test . This experiment was repeated in three separate, independent
trials.
Accession Codes
Coordinates and structure factors for Rock1 SBDSER have been
deposited at the Protein Data Bank and assigned the identifier
4L2W.
Results
Identification of a minimal Shrm binding domain
Multiple lines of investigation, including biochemical, structural,
and cellular analysis, have characterized and demonstrated the
importance of the Shrm-Rock interaction in the regulation of
cytoskeletal organization, cell shape, and tissue morphogenesis
[5,8–10,37,42]. Within Shrm, this interaction is mediated by a
highly conserved Shrm-domain 2 (SD2) found at the C-termini of
all Shrm proteins identified to date [35,37,42,44]. Shrm binding
capacity had been demonstrated for a large, central region within
the coiled-coil domain of Rock2 (amino acids 698–947) that is
distinct from the RhoA-binding domain, however residues that
specify this interaction within Rock1 have not been identified [37].
Therefore, we sought to define the Shrm-binding region within
Rock and determine the mechanism by which it interacts with the
SD2.
Since both Rock1 and Rock2 have been shown to bind the SD2
motif of Shrm, we reasoned there is a conserved sequence motif
within Rock that would mediate this interaction. Mapping
sequence conservation within an alignment of 22 Rock protein
sequences, we noted a region of high conservation within the SD2
binding region (Figure 1A, asterisk). Disorder profiles of the Rock1
sequence predict 834–913 as a stably folded fragment containing
this region of conservation. We then tested Rock1 proteins
containing residues 707–815, 707–913, 772–913, or 834–913, for
the ability to support Shrm SD2 binding in a pull-down assay. In
this assay, His6-tagged Rock1 fragments containing residues 707–
913, 772–913, or 834–913 bound to nickel resin were sufficient to
pull-down untagged human Shrm2 SD2 (Figure 1B). In contrast,
the 707–815 fragment of Rock1 was unable to pull down the SD2,
suggesting that the necessary sequence for Shrm binding contains
amino acids 815–913. We examined this interaction quantitatively
by labeling human Shrm2 SD2 with Oregon-Green at its N-
terminus and monitoring fluorescence anisotropy throughout a
titration of Rock (Figure 1C). We tested the ability of Rock1
proteins to bind in this assay; the first, containing residues 707–946
corresponds closely to the fragment initially shown to mediate
Shrm binding [37], while the second, comprised of residues 834–
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913, was identified based on conservation and verified in our
pulldowns. While binding affinity was somewhat reduced in this
assay for the smaller 834–913 fragment, both Rock1 proteins were
still capable of binding SD2 with affinities comparable to that
observed between Drosophila Rock and Shrm [42]. Together,
these data suggest that there is a stable Shrm binding domain
(SBD) composed of residues 834–913 of hRock1.
The structure of Rock1 SBD
It is interesting to note that the Rock SBD does not overlap with
those sequences previously identified as being involved in Rock
autoinhibition, raising the possibility that the mechanism by which
Shrm relieves Rock autoinhibition may be distinct from the
canonical activator RhoA. Alternatively, Shrm binding to Rock
may prevent autoinhibition in a manner that is similar to RhoA
but is functionally independent from RhoA. To understand the
details of the Rock-Shrm interaction and their mechanistic
implications, we obtained crystals of the human Rock1 SBD.
However, these crystals exhibited low resolution and anisotropic
diffraction and were unsuitable for structure determination.
Diffraction quality was greatly improved through the introduction
of a triple alanine mutation, 884EKE886, suggested by the Surface
Entropy Reduction server [55] and termed SBDSER.
Crystals of SBDSER belong to space group C21 and also exhibit
anisotropy with diffraction extending to 2.5 A˚ along a* and c* but
only 3.1 A˚ along the b* plane. The diffraction data were then
filtered to retain data within these resolution limits [50,56] (see
Materials and Methods and Table 1 for additional details
regarding the structure determination process). Phases were
determined using the SAD method, and the final model was
refined against native data at 2.5 A˚ resolution to Rwork and Rfree
values of 23.6% and 27.6% respectively. SBDSER crystals contain
two parallel coiled-coil dimers in the asymmetric unit packed in a
tail-to-tail arrangement (Figure 2A). Each SBD monomer is an
entirely helical segment ,100 A˚ in length and the completed
model minimally contains residues 838–902 from each molecule.
The two dimers in the asymmetric unit are essentially equivalent
with an r.m.s.d. of 1.0 A˚ over 131 Ca atoms.
The C-terminal end of each dimer is splayed open allowing the
formation of a helical bundle beginning at residue 875. The
SBDSER mutant that facilitates crystallization, positions 884–886,
is located within the center of this helical bundle. The alanines at
positions 884 and notably 885 are making hydrophobic contacts
with the other dimer within the asymmetric unit(Figure 2B).
Position 886 is surface exposed and does not appear to play a role
in facilitating crystallization. The helix is noticeably kinked after
the SBDSER positions suggesting that the substitutions at the
SBDSER positions may have altered the overall structure of the
SBD to favor the formation of a helical bundle between residues
875–902. To determine whether the SBDSER mutant was affecting
protein function, we first tested the oligomeric state of SBD and
SBDSER in solution by treating both proteins with the chemical
crosslinker glutaraldehyde and resolving the resulting species on
SDS-PAGE (Figure 2C). Both SBD and SBDSER readily formed
dimers in this assay. We next tested whether Shrm binding was
affected by the SBDSER substitution using native gel electropho-
resis. Shrm-Rock complexes are more readily visualized using a
larger hRock1 fragment, so we utilized amino acids 707–946 of
hRock1 in this assay. In this assay, either wildtype or an SBDSER
variant of 707–946 was mixed with human Shrm2 SD2 (in the
absence of crosslinker), and the proteins resolved by native PAGE.
As indicated by the formation of the slower migrating complex, the
wildtype and the SER variant exhibit roughly equivalent binding
to the SD2, supporting the view that the SBDSER variant of Rock1
is still biochemically functional (Figure 2D). Since SBDSER is
dimeric in solution, crystal packing forces, perhaps accentuated by
additional hydrophobic interactions found in the SBDSER variant,
are likely responsible for the observed helical bundle. This packing
arrangement was also observed in an unrelated segment of the
Rock1 coiled-coil [56].
A conserved region within the Rock coiled-coil mediates
Shrm binding
We used the multiple sequence alignment described earlier
(Figure 1A and Figure S1) to map sequence conservation onto the
surface of our SBDSER model, reasoning that residues mediating
the interaction to the conserved SD2 domain would also be
evolutionarily conserved. This analysis revealed the presence of a
large conserved stretch of amino acids formed by residues 837 to
866 (Figure S1), that were.95% identical across the sequences we
Table 1. Crystallographic Data collection and refinement
statistics for human Rock1 SBDSER.
SeMet Native
Data Collection
Space Group C21 C21
Cell Dimensions
a (A˚) 141.6 142.5
b (A˚) 56.1 56.2
c (A˚) 80.4 80.7
a, b, c (u) 90, 119.0, 90 90, 119.1, 90
Resolution (A˚) 50.0-2.4 (2.44-2.40) 50.0-2.5 (2.54-2.50)
Unique Reflections 21426 17172
Rmerge 8.7 (65.7) 7.6 (54.7)
I/sI 27.0 (1.6) 30.7 (1.9)
Completeness (%) 98.9 (93.8) 88.6 (56.1)
Redundancy 6.1 (4.1) 5.7 (4.9)
Refinement Statistics
Resolution (A˚) 50.0-2.5
Rwork/Rfree 23.59/27.56
No. atoms
Protein 4391
Solvent 27
R.m.s. deviations
Bond lengths (A˚) 0.006
Bond angles (u) 0.838
Isotropic B values (A˚2) 61.15
Protein 61.27
Water 50.93
Ramachandran
Favored 98.08
Allowed 1.92
Outliers 0
Values in parentheses correspond to those in the outer resolution shell.
Rmerge = (|(SI2,I.)|)/(SI), where ,I. is the average intensity of multiple
measurements.
Rwork =ShklIFobs(hkl)I2Fcalc (hkl)I/Shkl|Fobs(hkl)|.
Rfree = crossvalidation R factor for 7.3% of the reflections against which the
model was not refined.
doi:10.1371/journal.pone.0081075.t001
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analyzed. These were contained entirely within the canonically
packed region, while residues outside of 837–866 contained
comparatively fewer conserved residues (Figure 3A). However,
given the nature of the coiled-coil, many of these positions may be
conserved in order to maintain the coiled-coil dimer or preserve
helical propensity. Therefore we scored all atom positions within
our model based on their surface triplet propensity [57], an
algorithm designed to predict protein-protein and protein-ligand
interaction surfaces. Mapping these scores onto the surface of the
SBD structure reveals a high scoring patch, formed primarily by
residues Y851 and F852 (Figure 3B, red), that is contained within
the region of high conservation.
To address whether this patch is important for mediating the
Rock-Shrm interaction, we generated a series of mutants
throughout the Rock1 SBD (Figure 3A), and tested their ability
to form a stable complex with the SD2 by native gel electropho-
resis. Since the outer surface is quite extended, we chose to
generate amino acid substitutions in clusters of adjacent residues,
using knowledge of the structure and the coiled-coil heptad
positions to avoid changing residues critical for coiled-coil stability.
Expression constructs encoding human Rock1 707–946 with
alanine substitutions at the identified positions were generated and
the resulting proteins purified. We chose to utilize alanine
substitutions in order to preserve helical propensity. All of these
SBD variants purify equally well and exhibit similar mobility on a
native gel, indicating these alterations do not perturb dimerization
or the overall structural integrity of the protein. These SBD
variants were then tested for their ability to bind the SD2 domain
from human Shrm2 (Figure 3C). In comparison to wildtype
protein, amino acids substitutions at residues 865EE866 and
872RENLKKIQ879 (in which the underlined residues were
changed to alanine), had no effect on complex formation,
demonstrating that the central portion of the SBD does not play
an important role in Shrm binding. In contrast, two other
variants used in this study, 850QYF852 and 857KTQ859, formed
little to no complex with the SD2, indicating significant defects
in Shrm binding. These residues are located within the highly
conserved patch near the N-terminus of the SBD and
demonstrate that this surface plays a prominent role in Shrm
binding. The Rock multiple sequence alignment also indicated a
strongly conserved patch of residues at positions 897–906, which
was not visualized in its native conformation due to packing
forces and disorder after residue 902. To examine the role these
residues may play in Shrm binding we generated two additional
variants, 900ESE902 and 900ESEQLAR906. These variants were
slightly impaired, but not deficient, for Shrm binding by native
gel electrophoresis (Figure 3C).
To obtain a quantitative understanding of the effect of these
mutants on Shrm binding, we measured the effect of selected
Rock1 SBD mutants (850QYF852, 857KTQ859, and 900ESE902) on
binding affinity using fluorescence anisotropy as described earlier.
Consistent with our analysis by native PAGE, 900ESE902 had only
a modest impact on Shrm binding, resulting in an ,5.5-fold
decrease in binding affinity, while 850QYF852 and 857KTQ859 were
severely compromised, preventing an accurate measure of binding
affinity (Figure 4). While we cannot rule out a direct and important
role for residues 900–906, the data presented here are most
consistent with the presence of a single binding site for Shrm
Figure 2. Structure of Rock1 834–913. A) Two dimers of Rock1 SBD (blue and green) pack within the crystal in a tail-to-tail arrangement, forming
a central helical bundle flanked by regions of canonical coiled-coil. B) Cartoon view of interactions within the helical bundle mediated by the residues
884–886. Hydrophobic interactions mediated by A884 and A885 with canonical interface residues L888 and L892 are highlighted. C) SBDSER does not
alter the oligomeric state of SBD in solution. WT SBD and SBDSER were crosslinked with 0.002% glutaraldehyde and the resulting species separated by
SDS-PAGE. D) Rock1 SBD containing the SER mutant can still bind Shrm SD2. Human Shrm2 SD2 domain was incubated with the indicated Rock1
fragments and resolved by native gel electrophoresis.
doi:10.1371/journal.pone.0081075.g002
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located between 839–860, with surface exposed residues between
850–859 serving as critical binding determinants.
Residues important for Shroom-Rock colocalization
To investigate the role of the Shrm-Rock interaction in cellular
morphology, we first assessed the ability of Shrm to recruit amino
acids 681–942 of Rock1, containing the SBD, to specific
subcellular locations in Cos7 cells. For these studies we used the
short version of Shrm3 that lacks the N-terminal PDZ domain but
contains the actin-binding region and the SD2 domain. This
naturally occurring Shrm3 isoform binds both actin and Rock and
retains the ability to induce apical constriction in polarized
epithelial cells [44,58]. In these cells, Shrm3 localizes specifically to
actin stress fibers and cortical actin (Figure 5A) [44]. When co-
expressed with Shrm3, amino acids 681–942 of Rock are
efficiently recruited to actin stress fibers. Consistent with previous
results [42], recruitment is dependent on the SD2 domain, as a
variant of Shrm3 lacking the SD2 (Shrm3DSD2) is incapable of
recruiting Rock to stress fibers and the Rock protein is diffusely
distributed in the cytoplasm (Figure 5B). To verify that the SBD is
responsible for the co-localization of Rock with Shrm3, we tested a
number of SBD variants for Shrm3-dependent recruitment to
actin stress fibers in Cos7 cells. We designed and generated
mutations resulting in alanine substitution in highly conserved
stretches of amino acids that we predicted would disrupt either the
Rock-Shrm interface or perturb Rock coiled-coil interactions.
These mutated amino acid segments include L842L846L855,
842LQDQL846, 855LYKTQ859, and 856YKTQ859. All of these
Rock variants exhibited reduced recruitment to actin stress fibers
by Shrm3, albeit with different severity (Figure 5C–F). The
855LYKTQ859, and 856YKTQ859 alanine substitutions virtually
eliminated recruitment to stress fibers, indicating this region plays
a significant role in the Shrm-Rock interaction (Figure 5E and 5F).
Importantly, these data are consistent with in vitro binding
Figure 3. A conserved region on the SBD surface mediates Shrm binding. A) Surface view of the SBD dimer colored by sequence
conservation. Residues colored light blue are identical in.95% of the Rock sequences in our alignment, while residues that are invariant across all 14
sequences are color darker blue. Residues that were altered in our mutational analysis are labeled. B) Surface of the SBD dimer colored by Surface
Triplet Propensity. Scoring is colored as a heat map with lowest scores in dark blue and the highest scores in red. A prominent patch containing
residues Y851 and F852 is indicated. C) Residues within the conserved patch contribute to Shrm binding. Human Shrm2 SD2 was mixed with wild-
type Rock1 SBD or the indicated mutant and the formation of a Rock-Shrm complex was detected by native gel electrophoresis.
doi:10.1371/journal.pone.0081075.g003
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experiments described above. In contrast, the 842LQDQL846
variant exhibits reduced recruitment to stress fibers in cells
expressing Shrm3, suggesting that it plays a role in Shrm binding
but is not absolutely required (Figure 5D). It is interesting to note
that the triple Leucine substitution eliminated binding (Figure 5C).
This mutation was generated prior to solving the crystal structure
and was based on conservation and the hypothesis that these
residues could mediate Rock-Rock or Rock-SD2 binding via
coiled-coil or leucine zipper interactions. Combined with the
results described above and the crystal structure, we predict that
the triple leucine mutant may disrupt both the coiled-coil nature of
the rock dimer, mediated by residues L842and L846 , which are
buried, and the binding interface, mediated by L855, which is
surface exposed. Based on the large binding interface and
numerous other coiled-coil interactions, it is unlikely that this
mutation completely disrupts the dimer. However, it may cause
localized disruption of the dimer that perturbs the structure of the
SD2 binding sight. This is supported by our observations that the
triple leucine variant is expressed equally well in cells and bacteria
and exhibits similar elution profiles during purification.
To verify that the co-localization results were caused by the
inability of these Rock variants to interact with Shroom3, we
tested their ability to bind Shroom3 using a pulldown assay. To
accomplish this, the Rock SBD variants were expressed in
293HEK cells and assayed for the ability to bind purified GST-
Shrm3 SD2 immobilized on beads (Figure 5, right panels).
Consistent with the co-localization data, only the WT Rock SBD
protein is pulled down by GST-Shrm3 SD2, suggesting that the
Rock SBD substitution variants are incapable of binding to the
SD2.
To ensure that our results were not affected by our choice of cell
line and that the same mechanisms are used at the apical surface of
polarized epithelial cells, we verified the role of the SBD in Shrm-
Rock co-localization in MDCK cells. To accomplish this, we co-
expressed either WT Rock 681–942 or the 855LYKTQ859 to
855AAAAA859 variant with a previously described fusion protein,
EndoShrm3, that consists of the apically targeted transmembrane
Figure 4. Rock1 SBD variants show decreased interaction with
Shrm. Fluorescence anisotropy experiments monitored 50 nM Oregon-
Green labeled human Shrm2 SD2 domain with increasing concentra-
tions of Rock1 (707–946) containing the indicated amino acid
substitutions. The change in anisotropy was fit to Equation 1 to
determine binding affinities (Kd) as indicated.
doi:10.1371/journal.pone.0081075.g004
Figure 5. The Rock1 SBD is required for localization with
Shrm3. (A–F) Myc-tagged wild type or SBD variants of hRock1 (681–
942) were co-expressed with wildtype Shrm3 or a Shrm3 variant lacking
the SD2 in Cos7 cells and stained to detect Shrm3 (green) or the myc
tag (red). The right-hand panels in A, C–F depict the results of pulldown
assays to detect the interaction of the indicated SBD variant and the
Shrm3 SD2. Binding of the Rock SBD variants was tested by using
immobilized GST-Shrm3 SD2 and lysates from HEK293 cells expressing
the indicated SBD protein, followed by western blotting to detect the
myc-tagged SBD proteins. Input = total cell lysate, GST = pulldown using
GST bound to beads, GST-SD2 = GST-Shrm3-SD2 bound to beads.
Arrowhead denotes the myc-tagged Rock protein. (G–I) T23 MDCK
epithelial cells were transfected with expression vectors for EndoShrm3
and Rock1 SBD (G), EndoShrm3 and Rock1-SBD 855LYKTQ859 to
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protein Endolyn and the C-terminus of Shrm3 containing the SD2
[36]. EndoShrm3 is localized to the apical surface of polarized
cells and induces dramatic apical constriction. When co-expressed
in MDCK cells, we observe strong co-localization of EndoShrm3
and the Rock SBD (Figure 5G) at the apical surface. In contrast,
the 855LYKTQ859 to 855AAAAA859 variant is cytoplasmic and not
recruited to the apical surface with EndoShrm3 (Figure 5H). The
SD2 is required for this interaction as a version of EndoShrm3 that
lacks the SD2 does not cause apical constriction and does not
recruit wildtype SBD to the apical surface (Figure 5I). These data
indicate that the SD2-SBD interaction is required for efficient co-
localization of Shrm3 and Rock in vivo.
The SBD is required for Shroom3-induced apical
constriction
The above results indicate that a central coiled-region of Rock is
sufficient for Shrm3-mediated subcellular localization and that this
activity requires amino acids 855–859 of human Rock1. To
investigate the role of this interaction during apical contractility,
we have established a knock-down/add-back assay to evaluate the
ability of Rock variants to participate in Shrm3-mediated apical
constriction. We have previously engineered T23 MDCK cells
that inducibly express the EndoShrm3 fusion described above
[36]. Upon induction of EndoShrm3 via withdrawal of doxycyclin,
cells exhibit robust apical constriction and a marked disruption of
tight junction organization as judged by ZO1 staining (Figure 6A).
To dissect the mechanism of Rock function in this process, we
855AAAAA859 (H) or EndoShrm3DSD2 and Rock1-SBD (I), grown on
transwell filters overnight to form confluent monolayers, and stained to
detect EndoShrm3 (green) and Rock-SBD (red). Dashed lines indicate
the position of the Z-projections that are shown in the lower panels. Ap,
apical surface; Bsl, basal surface.
doi:10.1371/journal.pone.0081075.g005
Figure 6. Rock-Shrm interaction is required for apical constriction. (A) Parental or EndoShrm3 expressing T23 MDCK cells were treated with
either control or Rock1 and 2 specific siRNAs and stained to detect ZO1. (B) Western blot analysis of Rock1 and Rock 2 knock-down in MDCK cells. (C)
T23 MDCK cells expressing EndoShrm3 treated with Rock1/2 siRNA for 2 days, transfected with the indicated hRock1 expression vectors, grown on
transwell membranes for 24 hours, and stained to detect ZO1 and hRock1. Z-projections are shown in smaller panels. (D) Quantification of rescue of
apical constriction by Rock1 variants. Apical area, as determined by the outline of ZO1 staining, was measured for parental, EndoShrm3 (ES3)
expressing, and EndoShrm3 cells treated with Rock1 siRNA (+siRNA). For rescue experiments, apical areas of only those cells that expressed the
indicated Rock1 proteins (WT = wildtype, KD = kinase dead; IA = RhoA binding domain mutant, 5A = SBD mutant 855LYKTQ859 to 855AAAAA859) were
measured. Results are shown for 15 cells picked at random from a single experiment. The horizontal line indicates the average apical area while **
indicates p = 0.001 relative to the apical area of parental cells.
doi:10.1371/journal.pone.0081075.g006
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utilized siRNA-mediated knock-down of canine Rock1 and
Rock2. As demonstrated by western blotting, we can successfully
deplete Rock1 and Rock2 in MDCK cells (Figure 6B). Knock-
down of Rock1 or Rock2 independently is unable to prevent
SD2-induced apical constriction (data not shown) while simul-
taneous knock-down of both Rock1 and Rock2 effectively
prevents this phenotype, suggesting that Rock1 and Rock2 are
redundant in Shrm-induced apical constriction (Figure 6A).
Importantly, apical constriction is rescued following re-expres-
sion of human Rock1 in cells that have been treated with siRNA
(Figure 6C). The ability of Rock1 to restore apical constriction is
dependent on its catalytic activity, as a kinase dead Rock mutant
(K105A, KD) cannot restore apical constriction [30]. It should
be noted that both wildtype and the kinase dead Rock1 are
recruited to the apical surface (Figure 6C). Expression of
wildtype Rock1 in uninduced MDCK cells does not cause apical
constriction and is not recruited to the apical surface (data not
shown). In contrast to wildtype Rock1, the Rock1 variant
harboring the 855LYKTQ859 to 855AAAAA859 (Rock1-5A)
mutation is neither recruited to the apical surface nor able to
effectively rescue apical constriction (Figure 6C). To quantify
these data, the apical areas of indicated MDCK cell populations
were measured using the area enclosed by ZO1 as the readout
for apical area (Figure 6D). For the parental, EndoShrm3, and
siRNA treated cells, cells were selected at random and
measured. For the Rock1 rescue experiments, only those cells
that expressed the indicated Rock1 protein were measured.
Taken together, these data indicate that the ability of Rock1 to
mediate Shrm3 induced apical constriction is dependent on its
ability to bind the SD2.
It is currently unclear if the Shrm-Rock interaction is sufficient
to activate Rock or if binding to RhoA is also required. To address
this, we performed the above experiments with an I1009A (IA)
variant of Rock1 that is unable to bind active RhoA [59]. When
utilized in this assay, Rock1-IA is recruited to the apical surface
and effectively rescues apical constriction (Figure 6C and 6D). This
result would suggest that in this context, RhoA binding is not
necessary for Rock1 to mediate SD2-induced apical constriction.
However, it is possible that the enhanced apical localization and
over expression of Rock is sufficient to overcome the need for
active RhoA and additional experiments specifically addressing the
activation of Rock1 by the SD2 are necessary.
Figure 7. Opposing Shrm binding sites within the SBD. A) Surface representation of the Rock SBD colored by the effect of substitutions in cell
based and in vitro assays. Included are positions which altered Shrm colocalization (magenta), positions which affected SD2 binding in vitro (red),
residues which did not affect SD2 binding in vitro (green), and residues 900–902 which had a subtle affect on SD2 binding (pale green). B) Cutaway
view of the Shrm binding region. Ribbon diagram and positions of side chains with a demonstrated affect (sticks) are colored as above. Black
represents the Rock surface which has been cut away to reveal the backbone and side chains underneath. A hydrophobic patch comprised of
residues Y851, F852, and L855 is indicated for each binding site.
doi:10.1371/journal.pone.0081075.g007
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Discussion
The Shrm-Rock signaling module is critical for a number of
developmental processes and appears to represent a non-canonical
mechanism for the localized activation of actomyosin contractility
in polarized epithelial cells. To understand the nature of the Shrm-
Rock interaction, we have solved the crystal structure of the Shrm
Binding Domain of human Rock1. Consistent with other
structures of the Rock coiled-coil region, the SBD is a parallel,
coiled-coil dimer. Our data show that the interface between Rock
and the SD2 motif is conserved and represents a previously
unidentified binding surface in the coiled-coil region on Rock.
Based on our data, we predict that the Shrm binding activity is
encompassed within residues 842–859 of the human Rock 1SBD
(Figure 7A). Within this region, we have identified two highly
conserved surface patches consisting of 850QYF852 and 857KTQ859
that are essential for Shrm binding and likely constitute a portion of
the binding interface between Shrm and Rock. Further, all the
substitutions that were tested within the conserved sequence patch
resulted in a loss of Shrm binding or colocalization, demonstrating
that this patch is functionally important (Figure 7A). Due to the
nature of the SBD structure, there is a second equivalent conserved
binding patch residing on the opposing face of the coiled-coil. An
examination of residues in this region indicates that the side chains
for Y851, F852, and L855 are packed together to form a
hydrophobic patch that protrudes slightly from the rest of the
SBD surface (Figure 7B). This is the only significant hydrophobic
sequence within the 842–859 region of Rock1 and we speculate that
this hydrophobic patch is playing an important role in mediating
Rock-Shrm binding. Alternatively, it is possible that the binding
surface is more extensive, containing additional residues from both
chains of the Rock dimer, as would be predicted from sequence
conservation. K859 and Q850 would be attractive candidates for
inclusion into an alternative extended binding surface (Figure 7B).
Importantly, either possibility results in the formation of two
binding sites on opposite faces of the Rock coiled-coil. Currently,
the SBD substitutions that we have analyzed cannot distinguish
between these possibilities. However, it should be noted that both
models are consistent with our previous studies indicating that the
SBD-Rock complex is a heterotetramer consisting of a SBD dimer
and two SD2 molecules. Residues that are buried within the coiled-
coil and mediate strand interactions could abrogate binding in two
ways. First, defects in the coiled-coil might perturb the overall
structure of the dimer, thus distorting the binding site. Alternatively,
if residues from both monomers of Rock1 contribute to the Shrm
binding site, mutations that prevent coiled-coil formation within
Rock may ablate the binding site altogether.
Our data indicate that both Rock1 and Rock2 can function in
Shrm3-mediated apical constriction and changes in cell morphol-
ogy. This is consistent with previous results showing that the SD2
can bind both Rock1 and Rock2 [37]. Additionally, our in vitro
and in vivo approaches have identified residues that are essential
for binding and colocalization respectively, and these residues are
highly conserved in Rock proteins from most metazoans.
Exceptions are Rock proteins from C. elegans and sponges, in
which the LYKTQ sequence is not conserved. These were not
included in our alignment however because they also lack a
discernible Shrm homolog. These data suggest that the Shrm-
Rock interaction has been maintained across animal evolution and
may represent an ancient signaling module that regulates cell
behavior during morphogenic events.
Mapping of critical Shrm-binding residues indicates that they
are positioned within approximately 50 amino acids of the Rho-
binding domain. We have previously shown that the SD2 and
active RhoA can likely bind simultaneously to Rock in vitro [10].
However, we show here that Rock proteins lacking the RhoA
binding site are still apically recruited by Shrm3 and can mediate
apical constriction. Although this is an artificial system, these
results would suggest that while Rock can bind both Shrm and
RhoA, these binding events could independently regulate Rock
function during distinct biological processes. However, there
could be instances where inputs from both Shrm and RhoA are
required to get a specific degree of Rock activation or
localization. These results seem to contradict previous results
suggesting that Shroom-mediate apical constriction requires
RhoA activity [38]. While these previous studies placed RhoA in
the pathway, they did not place it upstream or downstream of
Shrm3 or Rock. It possible that RhoA activity is necessary for
the assembly and organization of the actin cytoskeleton
associated with apical cell-cell adhesions that are required for
proper Shrm3 localization. This is supported by the observation
that basally localized activated RhoA causes the redistribution
of ZO1 and Shrm3 to the basal surface [38]. This would suggest
that RhoA is upstream of Shrm3 localization and subsequent
apical constriction. This idea is further supported by results
showing that N-cadherin genetically interacts with Shrm3 in
mice [39]. Solving this issue will require direct measurements of
Rock catalytic activity in the presence of various combinations
of RhoA and Shrm.
The structural studies presented here indicate that the coiled-
coil region of Rock contains a well conserved binding site for
Shrm proteins. The fact that the SBD is clearly distinct from
other defined binding sites in the coiled-coil region of Rock adds
another layer complexity to the function and regulation of Rock
during numerous biological processes. Our results suggest that
Shrm binding is able to recruit Rock and may be sufficient to
activate it in the absence of RhoA binding. The ramifications
for this are many fold. First, it provides another pathway by
which cells can spatially control the activity of Rock in order to
regulate specific changes in cytoskeletal organization. Secondly,
this shows that there may be ways to target defined aspects of
Rock activity while leaving others untouched. This may allow
for more specific molecular dissection of Rock function in vivo
or as a way to target Rock activity for the purposes of
therapeutic development in the treatment of a variety of human
diseases.
Supporting Information
Figure S1 Diagram of Rock1 variants used in this study.
Sequence conservation within the SBD region is indicated through
an alignment of 22 Rock sequences. Residues colored blue in the
alignment are invariant across the aligned sequences. The location
of Rock1 variants generated in this study are indicated above
alignment and are colored by the effect of the substitution in the
indicated assay.
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